Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPreferred Stock LiabilitiesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Lifecore Biomedical, Inc. \De\ (LFCR) Non-Current Deferred Tax Liability (2016 - 2024)

Historic Non-Current Deferred Tax Liability for Lifecore Biomedical, Inc. \De\ (LFCR) over the last 14 years, with Q4 2024 value amounting to $552000.0.

  • Lifecore Biomedical, Inc. \De\'s Non-Current Deferred Tax Liability rose 3269.23% to $552000.0 in Q4 2024 from the same period last year, while for Nov 2024 it was $552000.0, marking a year-over-year increase of 3269.23%. This contributed to the annual value of $543000.0 for FY2024, which is 9618.55% down from last year.
  • As of Q4 2024, Lifecore Biomedical, Inc. \De\'s Non-Current Deferred Tax Liability stood at $552000.0, which was up 3269.23% from $443000.0 recorded in Q3 2024.
  • In the past 5 years, Lifecore Biomedical, Inc. \De\'s Non-Current Deferred Tax Liability registered a high of $41.0 million during Q2 2020, and its lowest value of $10000.0 during Q4 2022.
  • In the last 5 years, Lifecore Biomedical, Inc. \De\'s Non-Current Deferred Tax Liability had a median value of $998500.0 in 2021 and averaged $7.2 million.
  • Per our database at Business Quant, Lifecore Biomedical, Inc. \De\'s Non-Current Deferred Tax Liability tumbled by 9916.74% in 2022 and then surged by 406000.0% in 2023.
  • Over the past 5 years, Lifecore Biomedical, Inc. \De\'s Non-Current Deferred Tax Liability (Quarter) stood at $6.6 million in 2020, then crashed by 81.89% to $1.2 million in 2021, then crashed by 99.17% to $10000.0 in 2022, then surged by 4060.0% to $416000.0 in 2023, then surged by 32.69% to $552000.0 in 2024.
  • Its last three reported values are $552000.0 in Q4 2024, $443000.0 for Q3 2024, and $543000.0 during Q2 2024.